Entity
Description
  • Value proposition

    A digital health companion:
    Helping patients to have fewer symptoms and less sick days.

    BOOST Thyroid is an app helping people with hypothyroidism and Hashimoto’s.

    Hashimoto's is the most common autoimmune condition. Affecting over 200 million people, it causes an underactive thyroid and other health complications.

    We support patients and doctors by providing expansive tracking options and informational health content. Our goal is to reduce symptoms and enable preventive health management for all underactive thyroid patients.

    We’re the first iOS app to address hypothyroidism and Hashimoto’s in collaboration with healthcare professionals and researchers.

    With machine learning and empathic scientific information, we offer personalized options to improve and maintain health.

    BOOST Thyroid is a startup supported by VCs, Sanofi, IBB, the EU Horizon 2020 programme PERMIDES and INNOLABS, the German Ministry of Education Research (BMBF), the Vodafone institute F-LANE accelerator, and the Fast Track Malmö accelerator.

    The app was developed in 2016 in collaboration with the University of Oxford, Stanford University, Charité Berlin, and the University of Utah.

Corporate interactions BETA
Corporate TypeTweets Articles
Impact Hub
Impact Hub
Startup accelerator & VC, Civic and Social Organizations
Impact Hub
Startup accelerator & VC, Civic and Social Organizations
Other

24 Jul 2020


Bayer
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Not capitalistic
Not partnership
Event

27 Nov 2016


Vodafone Institute Vodafone Institute
Think Tanks
Other

27 Nov 2019


Similar entities
Loading...
Loading...
Social network dynamics